“Achieving Cannabis Cessation – Evaluating N-Acetylcysteine Treatment (Accent): Design And Implementation Of A Multi-Site, Randomized Controlled Study In The National Institute On Drug Abuse Clinical Trials Network”. Contemp Clin Trials 39. Contemp Clin Trials: 211-223. http://www.ncbi.nlm.nih.gov/pubmed/25179587.
. 2014. “Implications Of Modifying Study Eligibility Criteria Post-Initiation Of Recruitment”. In Society For Clinical Trials 35Th Annual Meeting. Society For Clinical Trials 35Th Annual Meeting. Philadelphia, PA. http://www.sctweb.org/public/meetings/2014/home.cfm.
. 2014. “Internet-Delivered Treatment For Substance Abuse: A Multisite Randomized Controlled Trial”. Am J Psychiatry 171. Am J Psychiatry: 683-690. http://www.ncbi.nlm.nih.gov/pubmed/24700332.
. 2014. “Non Clinical Parameters Affecting Primary Cesarean Rates In The United States”. Am J Perinatol 31. Am J Perinatol: 213-222. http://www.ncbi.nlm.nih.gov/pubmed/23670226.
. 2014. “Patient Registries For Substance Use Disorders”. Subst Abuse Rehabil 5. Subst Abuse Rehabil: 81-86. http://www.ncbi.nlm.nih.gov/pubmed/25114612.
. 2014. “Tracking And Monitoring Trial Progress In Nida Ctn Studies”. In Nih Workshop On Enrollment And Retention Of Participants In Nih-Funded Clinical Trials. Nih Workshop On Enrollment And Retention Of Participants In Nih-Funded Clinical Trials. Bethesda, MD. http://osp.od.nih.gov/office-clinical-research-and-bioethics-policy/event/2014-07-25-121500-2014-07-25-214500/nih-workshop-enrollment-and-retention-participants-nih-funded-clinical-trials.
. 2014. “Body Mass Index (Bmi) And Obesity Prevalence Among Substance Abuse Participants From Nida’S Clinical Trials Network (Ctn)”. In College On Problems Of Drug Dependence Meeting. College On Problems Of Drug Dependence Meeting. San Diego, CA. http://www.cpdd.vcu.edu/index.html.
. 2013. “Induction Onto Extended-Release Naltrexone In 302 Cocaine-Dependent Opioid Users”. In College On Problems Of Drug Dependence Meeting. College On Problems Of Drug Dependence Meeting. San Diego CA. http://www.cpdd.vcu.edu/index.html.
. 2013. “Investigator Attestation Poster”. In Society Of Clinical Research Associates - Socra, 22Nd Annual Conference. Society Of Clinical Research Associates - Socra, 22Nd Annual Conference. http://www.socra.org/.
. 2013. . 2013.
“Score Study Report 12: Development Of Venous Collaterals In The Score Study”. Retina 33. Retina: 287-295. http://www.ncbi.nlm.nih.gov/pubmed/22972448.
. 2013. “Clinical Trial Management: Monitoring Progress, Sites And Safety; New Paradigms For Efficiency”. In 5Th Annual Clinical Research Management Workshop At The Yale Center For Clinical Investigation. 5Th Annual Clinical Research Management Workshop At The Yale Center For Clinical Investigation. New Haven, CT. http://ycci.yale.edu/news/crm2012.aspx.
. 2012. “Design And Methodological Considerations Of An Effectiveness Trial Of A Computer-Assisted Intervention: An Example From The Nida Clinical Trials Network”. Contemp Clin Trials 33. Contemp Clin Trials: 386-395. http://www.ncbi.nlm.nih.gov/pubmed/22085803.
. 2012. “Estimating Death Rates In Substance Use Disorder”. In The Society For Clinical Trials 33Rd Annual Meeting. The Society For Clinical Trials 33Rd Annual Meeting. Miami, FL. http://www.sctweb.org/public/meetings/2012/home.cfm.
. 2012. “Evaluation Of Buspirone For Relapse-Prevention In Adults With Cocaine Dependence: An Efficacy Trial Conducted In The Real World”. Contemp Clin Trials 33. Contemp Clin Trials: 993-1002. http://www.ncbi.nlm.nih.gov/pubmed/22613054.
. 2012. “How Electronic Health Records (Ehrs) Can Support Comparative Effectiveness Research (Cer)”. In Annual Comparative Effectiveness Research Key Function Committee Meeting. Annual Comparative Effectiveness Research Key Function Committee Meeting. Rockville, MD. http://www.nlm.nih.gov/hsrinfo/cer.html.
. 2012. “Implementation Of A Drug Management Utility In A Multi-Site, Randomized, Double-Blinded Study”. In Society For Clinical Trials Annual Meeting. Society For Clinical Trials Annual Meeting. Miami, FL. http://www.sctweb.org/public/meetings/2012/home.cfm.
. 2012. “Baseline Predictors Of Visual Acuity And Retinal Thickness Outcomes In Patients With Retinal Vein Occlusion. Score Study Report 10”. Ophthalmology 118. Ophthalmology: 345-352. http://www.ncbi.nlm.nih.gov/pubmed/20926135.
. 2011. “Characteristics Associated With Severe Perineal And Cervical Lacerations During Vaginal Delivery”. Obstet Gynecol 117. Obstet Gynecol: 627-635. http://www.ncbi.nlm.nih.gov/pubmed/21343766.
. 2011. “A Comparison Of Obstetric Maneuvers For The Acute Management Of Shoulder Dystocia”. Obstet Gynecol 117. Obstet Gynecol: 1272-1278. http://www.ncbi.nlm.nih.gov/pubmed/21555962.
. 2011. “Power Of Automated Algorithms For Combining Time-Line Follow-Back And Urine Drug Screening Test Results In Stimulant-Abuse Clinical Trials”. Am J Drug Alcohol Abuse 37. Am J Drug Alcohol Abuse: 350-357. http://www.ncbi.nlm.nih.gov/pubmed/21854277.
. 2011. “Score Study Report #11: Incidences Of Neovascular Events In Eyes With Retinal Vein Occlusion”. Ophthalmology 118. Ophthalmology: 1364-1372. http://www.ncbi.nlm.nih.gov/pubmed/21440942.
. 2011. “Contemporary Cesarean Delivery Practice In The United States”. Am J Obstet Gynecol 203. Am J Obstet Gynecol: 326.e321-326.e310. http://www.ncbi.nlm.nih.gov/pubmed/20708166.
. 2010. “Contemporary Patterns Of Spontaneous Labor With Normal Neonatal Outcomes”. Obstet Gynecol 116. Obstet Gynecol: 1281-1287. http://www.ncbi.nlm.nih.gov/pubmed/21099592.
. 2010. “Maternal And Neonatal Outcomes By Labor Onset Type And Gestational Age”. Am J Obstet Gynecol. 202. Am J Obstet Gynecol.: 245.e241-245.e212. http://www.ncbi.nlm.nih.gov/pubmed/20207242.
. 2010.